Exact Sciences Announces Preliminary Fourth Quarter 2020 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/24/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Exact Sciences (EXAS) PT Raised to $161 at Oppenheimer
January 12, 2021 7:37 AM ESTOppenheimer analyst Kevin DeGreeter raised the price target on Exact Sciences (NASDAQ: EXAS) to $161.00 (from $153.00) while maintaining an Outperform rating.
The analyst commented, "Raising PT from $153 to $161 based on stronger-than-expected 4Q20 top-line growth(preliminary of $464.5-467.5M vs our prior estimate of $443.0M).... More
